Article

The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia

Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
PLoS Genetics (Impact Factor: 8.17). 08/2010; 6(8). DOI: 10.1371/journal.pgen.1001051
Source: PubMed

ABSTRACT Genome-wide association studies of lung cancer reported in populations of European background have identified three regions on chromosomes 5p15.33, 6p21.33, and 15q25 that have achieved genome-wide significance with p-values of 10(-7) or lower. These studies have been performed primarily in cigarette smokers, raising the possibility that the observed associations could be related to tobacco use, lung carcinogenesis, or both. Since most women in Asia do not smoke, we conducted a genome-wide association study of lung adenocarcinoma in never-smoking females (584 cases, 585 controls) among Han Chinese in Taiwan and found that the most significant association was for rs2736100 on chromosome 5p15.33 (p = 1.30 x 10(-11)). This finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls (p = 5.38 x 10(-11)). A pooled analysis achieved genome-wide significance for rs2736100. This SNP marker localizes to the CLPTM1L-TERT locus on chromosome 5p15.33 (p = 2.60 x 10(-20), allelic risk = 1.54, 95% Confidence Interval (CI) 1.41-1.68). Risks for heterozygote and homozygote carriers of the minor allele were 1.62 (95% CI; 1.40-1.87), and 2.35 (95% CI: 1.95-2.83), respectively. In summary, our results show that genetic variation in the CLPTM1L-TERT locus of chromosome 5p15.33 is directly associated with the risk of lung cancer, most notably adenocarcinoma.

Download full-text

Full-text

Available from: Mingfeng Zhang, Sep 01, 2015
0 Followers
 · 
258 Views
 · 
57 Downloads
  • Source
    • "To date, the molecular mechanism by which fascin is involved in tumor invasion is largely unknown. As described earlier for cholangiocarcinoma [26], fascin participates in the tumor necrosis factor-␣-induced up-regulation of matrix metalloprotease-9 (MMP-9) and might be regulated by multiple signaling cascades, including those involving NF-␬B, Erk1/2, and p38 MAPK. Studies of breast cancer have shown that fascin downregulates the metastasis suppressor, breast cancer metastasis suppressor 1, and induces the expression of urokinase-type plasminogen activator and MMPs such as MMP-2 and -9 through the up-regulation of NF-␬B activity [30]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fascin, a conserved actin bundling protein family member, is frequently up-regulated in various cancer types, including non-small-cell lung cancer (NSCLC), and it plays increasingly important roles in the progression of tumor invasion and metastasis. However, variations in the serum fascin level in tumor patients are usually neglected. In the present study, serum samples from 501 stage I-IV NSCLC patients and 109 healthy volunteers were investigated by an enzyme-linked immunosorbent assay. The serum fascin level was markedly increased in the NSCLC patients (P<0.05), particularly in advanced cases (P<0.01), compared with that in the healthy controls. We also found that the serum fascin level was significantly correlated with female sex (P=0.02), non-smoking status (P=0.044), and adenocarcinoma histology (P<0.001), with a higher positive rate relative to each counterpart. Furthermore, our results suggested that the serum fascin level reflects the aggressive progress of both lymphatic (P<0.001) and distant (P<0.001) metastases in NSCLC. A survival analysis of 283 eligible patients who underwent a follow-up examination after 3 years revealed that the patients in the serum fascin-positive group had a significantly lower overall survival rate compared with those in the negative group for 134 non-distant metastatic (stage M0) cases (P=0.044). A subsequent Cox regression analysis revealed that the serum fascin level was an independent prognostic factor for M0-stage NSCLC (univariate, P=0.001; multivariate, P=0.038). Our study suggests that the serum fascin level is an effective indicator of tumor aggressiveness, and that it plays an important role in the prognosis of NSCLC, particularly for non-distant metastatic patients.
    Lung cancer (Amsterdam, Netherlands) 09/2013; 82(2). DOI:10.1016/j.lungcan.2013.08.017 · 3.74 Impact Factor
  • Source
    • "A recent study of lung cancer in never-smoking women in Asia (25) indicated that rs7086803 of the VTI1A gene on chromosome 10q25.2 is associated with lung carcinogenesis. The inconsistent observations in several GWA studies might be attributed to different environmental exposures, ethnic differences (21, 22, 24), mixed histology (23, 24), sex (22-24), and smoking history (23, 24), or different SNP markers (21, 22, 25). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer in never-smokers ranks as the seventh most common cause of cancer death worldwide, and the incidence of lung cancer in non-smoking Korean women appears to be steadily increasing. To identify the effect of genetic polymorphisms on lung cancer risk in non-smoking Korean women, we conducted a genome-wide association study of Korean female non-smokers with lung cancer. We analyzed 440,794 genotype data of 285 cases and 1,455 controls, and nineteen SNPs were associated with lung cancer development (P < 0.001). For external validation, nineteen SNPs were replicated in another sample set composed of 293 cases and 495 controls, and only rs10187911 on 2p16.3 was significantly associated with lung cancer development (dominant model, OR of TG or GG, 1.58, P = 0.025). We confirmed this SNP again in another replication set composed of 546 cases and 744 controls (recessive model, OR of GG, 1.32, P = 0.027). OR and P value in combined set were 1.37 and < 0.001 in additive model, 1.51 and < 0.001 in dominant model, and 1.54 and < 0.001 in recessive model. The effect of this SNP was found to be consistent only in adenocarcinoma patients (1.36 and < 0.001 in additive model, 1.49 and < 0.001 in dominant model, and 1.54 and < 0.001 in recessive model). Furthermore, after imputation with HapMap data, we found regional significance near rs10187911, and five SNPs showed P value less than that of rs10187911 (rs12478012, rs4377361, rs13005521, rs12475464, and rs7564130). Therefore, we concluded that a region on chromosome 2 is significantly associated with lung cancer risk in Korean non-smoking women.
    Journal of Korean medical science 06/2013; 28(6):840-7. DOI:10.3346/jkms.2013.28.6.840 · 1.25 Impact Factor
  • Source
    • "(MTMR-HORMAD2-LIF) that are associated with lung cancer risk [3] [4] [5] [6] [7] [8] [9] [10] [11] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Runs of homozygosity (ROHs) are a class of important but poorly studied genomic variations and may be involved in individual susceptibility to diseases. To better understand ROH and its relationship with lung cancer, we performed a genome-wide ROH analysis of a subset of a previous genome-wide case-control study (1,473 cases and 1,962 controls) in a Han Chinese population. ROHs were classified into two classes, based on lengths, intermediate and long ROHs, to evaluate their association with lung cancer risk using existing genome-wide single nucleotide polymorphism (SNP) data. We found that the overall level of intermediate ROHs was significantly associated with a decreased risk of lung cancer (odds ratio = 0.63; 95% confidence interval: 0.51-0.77; P = 4.78×10(-6) ), while the long ROHs seemed to be a risk factor of lung cancer. We also identified one ROH region at 14q23.1 that was consistently associated with lung cancer risk in the study. These results indicated that ROHs may be a new class of variation which may be associated with lung cancer risk, and genetic variants at 14q23.1 may be involved in the development of lung cancer.
    05/2013; 27(3):208-214. DOI:10.7555/JBR.27.20130017
Show more